Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Article

    Polydatin Lowers Serum Uric Acid Levels by Increasing its Excretion and Suppressing Production

    Shuxie Wu1, Gao Wu2, Hong Jiang2, Hanbin Wu3 Corresponding author

    1. 1Department of Gynecology, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200080, China.
    2. 2Department of Pharmacy, First Affiliated Hospital of Naval Military Medical University, Shanghai, 200081, China.
    3. 3Department of Pharmacy, First Affiliated Hospital of Naval Military Medical University, Shanghai 200120, China.

    CORRESPONDENCE

    Shuxie Wu

    Department of Gynecology, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200080, China.

    wuhanbin2000@163.com

    Received: 14-07-2021; Revised: 05-05-2022; Accepted: 01-08-2022.

    Volume 18, Issue 80 · pp. 1089–1095 · PUBLISHED 23 November 2022 · DOI: 10.4103/pm.pm_309_21

    View on Pharmacogn. Mag. original site ↗

    ABSTRACT

    Background: Polydatin has significant uricosuric effects. This study was conducted to examine the xanthine oxidase inhibition and to detect protein levels of urate transporter 1 (URAT1), organic anion transporters 1 (OAT1), and organic anion transporters 3 (OAT3) in the hyperuricemic mice to understand the role of antihyperuricemic mechanism of polydatin. Materials and Methods: Hyperuricemia mice model was established with uricase inhibitor (potassium oxonate), and uric acids in serum were observed. Kidney tissues were used to detect gene contents of URAT1, OAT1, and OAT3 by real‑time‑PCR (polymerase chain reaction) and to detect pathological features. The activity of xanthine oxidase (XOD) in the liver tissues of mice was detected. Results: The polydatin experimental groups and the positive control group (benzbromarone) showed significantly inhibited levels of serum uric acid when compared with the model group. Polydatin significantly inhibited the increasing tendency of the mRNA and the protein levels of OAT1 and OAT3, and decreased the tendency of the mRNA and the protein level of URAT1. Polydatin significantly inhibited the level of XOD in the liver tissues of mice in a concentration‑dependent manner. Polydatin showed a protective effect on the pathological injury of the kidney. Conclusion: Polydatin has an antihyperuricemic effect in oxonate‑induced hyperuricemic mice. The effect was related to the downregulation of renal URAT1, upregulation of renal OAT1 and OAT3, and inhibition of XOD in the hyperuricemic mice.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Wu, S., Wu, G., Jiang, H., & Wu, H. (2022). Polydatin Lowers Serum Uric Acid Levels by Increasing its Excretion and Suppressing Production. Pharmacognosy Magazine, 18(80), 1089–1095. https://doi.org/10.4103/pm.pm_309_21